Targeting telomeric DNA damage response as a new strategy to fight immunosenescence and improve vaccine response
The project aims to evaluate the effectiveness of telomeric antisense oligonucleotides in rejuvenating the immune response and enhancing vaccine efficacy in aged mice.
Projectdetails
Introduction
The immune system is remodeled with age, going through a series of changes known as immunosenescence. These changes include:
- The involution of primary lymphoid organs
- The contraction of the immune repertoire
- A progressive lineage skewing towards the myeloid lineage
- A low-grade pro-inflammatory status
A consequence of immunosenescence impacting the morbidity and mortality of infectious diseases is a dramatically reduced vaccine response in the elderly. Thus, reducing the burden of immunosenescence has the potential to impact the effectiveness of vaccine response.
Telomere Dysfunction
An established hallmark and driver of age-associated functional decline is telomere dysfunction. Dysfunctional telomeres are actively transcribed to generate telomeric non-coding RNAs (tncRNA), which are essential to recruit DNA Damage Response (DDR) factors at damaged telomeres. This process fuels DDR and causes cellular senescence initiation and maintenance.
Telomeric Antisense Oligonucleotides
Sequence-specific telomeric antisense oligonucleotides (tASOs) target these tncRNAs and effectively inhibit DDR activation, ameliorating age-related phenotypes in mouse models.
Mouse Model
The telomerase-deficient (Terc-/-) mouse model causes telomere shortening and dysfunction, recapitulating features of immunosenescence, including:
- Immune system reactivity reduction
- Decreased long-term renewal of hematopoietic stem cells
- Decreased lymphocyte numbers
- Increased neutrophil count
tASOs treatment has a beneficial long-term effect in this model by decreasing immunosenescence and counteracting inflammation.
Future Plans
We now plan to test the efficacy of tASOs treatment on rejuvenating the immune system of aged wild type mice, which represents a physiological setting for aging.
Goals
The final goal will be to assess if tASOs impact vaccine response in both models:
- Young Terc-/- mice
- Aged WT mice
In summary, we plan to determine the efficacy of tASOs to improve immune responses, including vaccines, in the elderly.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 150.000 |
Totale projectbegroting | € 150.000 |
Tijdlijn
Startdatum | 1-9-2023 |
Einddatum | 28-2-2025 |
Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- IFOM-ISTITUTO FONDAZIONE DI ONCOLOGIA MOLECOLARE ETSpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
MANUNKIND: Determinants and Dynamics of Collaborative ExploitationThis project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery. | ERC STG | € 1.497.749 | 2022 | Details |
Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressureThe UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance. | ERC STG | € 1.498.280 | 2022 | Details |
Uncovering the mechanisms of action of an antiviral bacteriumThis project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function. | ERC STG | € 1.500.000 | 2023 | Details |
The Ethics of Loneliness and SociabilityThis project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field. | ERC STG | € 1.025.860 | 2023 | Details |
MANUNKIND: Determinants and Dynamics of Collaborative Exploitation
This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.
Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure
The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.
Uncovering the mechanisms of action of an antiviral bacterium
This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.
The Ethics of Loneliness and Sociability
This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Elucidating and targeting the mechanisms encoded in the genome of long-lived individuals to improve healthy ageingThis project aims to identify and validate rare genetic variants linked to longevity using CRISPR/Cas9 and high-throughput screening to promote healthy aging and extend lifespan. | ERC STG | € 1.500.000 | 2022 | Details |
Letting up senescence and inflammaging through T cellsLetTBe aims to investigate T cell metabolism and its role in aging to develop strategies that prevent immunosenescence and promote healthy aging. | ERC COG | € 1.999.944 | 2023 | Details |
Reversing T cell dysfunction in cancer by multimodal genetic screeningThis project aims to validate and characterize genes reversing T cell dysfunction in vivo to enhance immunotherapy effectiveness against cancer. | ERC ADG | € 2.499.375 | 2022 | Details |
In vivo metabolic determinants of T cell aging trajectoriesThis project aims to uncover how aging microenvironments affect T cell immunity and explore methods to rejuvenate T cells to combat age-related diseases. | ERC STG | € 1.500.000 | 2023 | Details |
Elucidating and targeting the mechanisms encoded in the genome of long-lived individuals to improve healthy ageing
This project aims to identify and validate rare genetic variants linked to longevity using CRISPR/Cas9 and high-throughput screening to promote healthy aging and extend lifespan.
Letting up senescence and inflammaging through T cells
LetTBe aims to investigate T cell metabolism and its role in aging to develop strategies that prevent immunosenescence and promote healthy aging.
Reversing T cell dysfunction in cancer by multimodal genetic screening
This project aims to validate and characterize genes reversing T cell dysfunction in vivo to enhance immunotherapy effectiveness against cancer.
In vivo metabolic determinants of T cell aging trajectories
This project aims to uncover how aging microenvironments affect T cell immunity and explore methods to rejuvenate T cells to combat age-related diseases.